Loading asset research
0.00%
Today
Loading 1D prices…
Company profile
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Gaithersburg, MD, United States
Employees
2
Fiscal year end
1231
CIK
1757499
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| PPCBPropanc Biopharma Inc. Common Stock | $2.1M | $0.00 | — | -$23.82 | -2.34% | Unrated |
| VBIOValion Bio Inc. Common Stock | $2M | $0.00 | — | -$196.00 | +2.73% | Unrated |
| OGENOragenics Inc. Common Stock | $2.2M | $0.00 | — | -$4.56 | -4.40% | Unrated |
| BTAIBioXcel Therapeutics Inc. Common Stock | $2.3M | $642K | -10887.38% | -$5.73 | +2.00% | Buy |
| NXTSNexentis Technologies Inc. Common Stock | $2.4M | $0.00 | — | -$8.61 | -4.14% | Unrated |